Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « Martin Soubrier »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Martin R. Wilkins < Martin Soubrier < Martina Finetti  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000050 (2019-06-12) Kedra Joanna [France] ; Philippe Dieudé [France] ; Hubert Marotte [États-Unis] ; Alexandre Lafourcade [France] ; Emilie Ducourau [France] ; Thierry Schaeverbeke [France] ; Aleth Perdriger [France] ; Martin Soubrier [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Emmanuelle Dernis [France] ; Valérie Royant [France] ; Jean-Hugues Salmon [France] ; Thao Pham [France] ; Jacques-Eric Gottenberg [France] ; Edouard Pertuiset [France] ; Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Philippe Gaudin [France] ; Gregoire Cormier [France] ; Philippe Goupille [France] ; Xavier Mariette [France] ; Francis Berenbaum [France] ; Didier Alcaix [France] ; Sid Ahmed Rouidi [France] ; Jean-Marie Berthelot [France] ; Agnès Monnier [France] ; Christine Piroth [France] ; Frederic Liote [France] ; Vincent Goeb [France] ; Cécile Gaujoux-Viala [France] ; Isabelle Chary Valckenaere [France] ; David Hajage [France] ; Florence Tubach [France] ; Bruno Fautrel [France]Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission
000112 (2019) Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
000118 (2019) Benjamin Castagné [France] ; Marie Viprey [France] ; Julie Martin [France] ; Anne-Marie Schott [France] ; Michel Cucherat [France] ; Martin Soubrier [France]Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
000177 (2018) Clément Lahaye [France] ; Zuzana Tatar [France] ; Jean-Jacques Dubost [France] ; Anne Tournadre [France] ; Martin Soubrier [France]Management of inflammatory rheumatic conditions in the elderly
000219 (2017-11-03) Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Elodie Perrodeau [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries
000220 (2017-07-14) Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis [France] ; René-Marc Flipo [France] ; Stéphanie Rist [France] ; Bernard Combe [France] ; Jacques-Eric Gottenberg [France] ; Thierry Schaeverbeke [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Maxime Dougados [France] ; Alain Saraux [France] ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French registry REGATE
000235 (2017) Jean-Jacques Dubost [France] ; Bruno Pereira [France] ; Anne Tournadre [France] ; Zuzana Tatar [France] ; Marion Couderc [France] ; Martin Soubrier [France]The changing face of septic arthritis complicating rheumatoid arthritis in the era of biotherapies. Retrospective single-center study over 35years.
000245 (2017) Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis ; René Marc Flipo ; Stéphanie Rist ; Bernard Combe [France] ; Jacques Eric Gottenberg [France] ; Thierry Schaeverbeke ; Martin Soubrier ; Olivier Vittecoq ; Maxime Dougados [France] ; Alain Saraux ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE.
000270 (2017) Cynthia Nourisson [France] ; Martin Soubrier [France] ; Aurélien Mulliez [France] ; Athan Baillet [France] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Olivier Vittecoq [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France] ; Anne Tournadre [France]Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the ‘ORA’ registry
000319 (2016) Éric Toussirot [France] ; Antoine Martin [France] ; Martin Soubrier [France] ; Serge Redeker [France] ; Alexis Régent [France]Rapid and Sustained Response to Tocilizumab in Patients with Polymyalgia Rheumatica Resistant or Intolerant to Glucocorticoids: A Multicenter Open-label Study.
000327 (2016) Cindy Mourgues [France] ; Cecile Henquell [France] ; Zuzana Tatar [France] ; Bruno Pereira [France] ; Cinthya Nourisson [France] ; Anne Tournadre [France] ; Martin Soubrier [France] ; Marion Couderc [France]Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis.
000341 (2016) Martin Soubrier [France] ; Jinglan Pei [États-Unis] ; Frédérick Durand [France] ; Lars Gullestad [Norvège] ; Ani John [États-Unis]Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
000491 (2013) Martin Soubrier [France] ; Zuzana Tatar ; Marion Couderc ; Sylvain Mathieu ; Jean-Jacques DubostRheumatoid arthritis in the elderly in the era of tight control.
000501 (2013) Sylvain Mathieu [France] ; Marion Couderc [France] ; Baptiste Glace [France] ; Bruno Pereira [France] ; Anne Tournadre [France] ; Jean-Jacques Dubost [France] ; Martin Soubrier [France]Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
000608 (2013) Martin Soubrier [France] ; Zuzana Tatar [France] ; Marion Couderc [France] ; Sylvain Mathieu [France] ; Jean-Jacques Dubost [France]Rheumatoid Arthritis in the Elderly in the Era of Tight Control
000618 (2012) Fernando Kemta Lekpa [France] ; Cécile Poulain [France] ; Daniel Wendling [France] ; Martin Soubrier [France] ; Michel De Bandt [France] ; Jean Marie Berthelot [France] ; Philippe Gaudin [France] ; Eric Toussirot [France] ; Philippe Goupille [France] ; Thao Pham [France] ; Jérémie Sellam [France] ; Rémy Bruckert [France] ; Muriel Paul [France] ; Valérie Farrenq [France] ; Pascal Claudepierre [France]Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study
000717 (2010) Zuzana Kubandova [France] ; Sylvain Mathieu [France] ; Claire Pourtier [France] ; Martin Soubrier [France]Zona grave dans la polyarthrite rhumatoïde au cours d'un traitement par anti-IL6

List of associated KwdEn.i

Nombre de
documents		Descripteur
8Humans
6Arthritis, Rheumatoid (drug therapy)
6Female
6Male
5Aged
5Middle Aged
4Adult
4Antibodies, Monoclonal, Humanized (administration & dosage)
4Arthritis, Rheumatoid (diagnosis)
3Antibodies, Monoclonal, Humanized (adverse effects)
3Cohort Studies
3Follow-Up Studies
3France (epidemiology)
3Prospective Studies
3Risk Assessment
3Treatment Outcome
2Antibodies, Monoclonal, Humanized (therapeutic use)
2Antirheumatic Agents (adverse effects)
2Chronic
2Drug Resistance
2Incidence
2Patient Safety
2Prognosis
2Retrospective Studies
2Rheumatoid arthritis
2Rituximab (adverse effects)
2Severity of Illness Index
2Tumor Necrosis Factor-alpha (antagonists & inhibitors)
1
1Abatacept (administration & dosage)
1Abatacept (adverse effects)
1Adalimumab (adverse effects)
1Adalimumab (therapeutic use)
1Adrenal Cortex Hormones (therapeutic use)
1Aged, 80 and over
1Antibodies, Monoclonal, Humanized (metabolism)
1Antirheumatic Agents (administration & dosage)
1Antirheumatic Agents (therapeutic use)
1Arthritis, Infectious (epidemiology)
1Arthritis, Infectious (etiology)
1Arthritis, Infectious (physiopathology)
1Arthritis, Rheumatoid (blood)
1Arthritis, Rheumatoid (complications)
1Arthritis, Rheumatoid (epidemiology)
1Arthritis, Rheumatoid (therapy)
1Arthritis, Rheumatoid (virology)
1Autoantibodies (blood)
1Biological Factors (therapeutic use)
1Biological Products (adverse effects)
1Biological Products (therapeutic use)
1Biological Therapy
1Biotherapy
1Cardiovascular Diseases (prevention & control)
1Chi-Square Distribution
1Cytomegalovirus (isolation & purification)
1Drug Delivery Systems (methods)
1Drug Monitoring (methods)
1Drug Monitoring (statistics & numerical data)
1Drug Therapy, Combination
1Drug Therapy, Combination (methods)
1Drug Therapy, Combination (statistics & numerical data)
1Elderly
1Etanercept (adverse effects)
1Etanercept (therapeutic use)
1Glucocorticoids (administration & dosage)
1Herpes zoster
1Herpesvirus 3, Human (isolation & purification)
1Herpesvirus 4, Human (isolation & purification)
1Immunomodulator
1Interleukin-6 (antagonists & inhibitors)
1Interleukin-6 (metabolism)
1Isoxazoles (adverse effects)
1Leflunomide
1Leukocyte Count
1Network Meta-Analysis
1Neutrophils
1Opportunistic Infections (chemically induced)
1Opportunistic Infections (epidemiology)
1Outcome Assessment, Health Care
1Peptides, Cyclic (immunology)
1Polymyalgia Rheumatica (diagnosis)
1Polymyalgia Rheumatica (drug therapy)
1Proportional Hazards Models
1Registries
1Review
1Rheumatology
1Risk Factors
1Rituximab (administration & dosage)
1Rituximab (therapeutic use)
1Spondylarthritis (drug therapy)
1Spondylarthritis (metabolism)
1Statistics, Nonparametric
1Survival Analysis
1Survival Rate
1Time Factors
1Tocilizumab
1Treatment
1Tumor Necrosis Factor-alpha (metabolism)
1Viral Load (drug effects)
1corticosteroids

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Martin Soubrier" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Martin Soubrier" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Martin Soubrier
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021